Migraine, 16 trials with monoclonal antibodies at San Raffaele (Italy): "formidable prevention…
Migraine, a new treatment pathway could involve the use of monoclonal antibodies: this is what is envisaged in 16 clinical trials at IRCCS San Raffaele